Showing results (21-30 of 294) with videos related to
Sort By:
Pageof 30
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 26, 2024
Committee of the new positions of the Société française de radiothérapie oncologique: Toward an advanced practice master in radiotherapySophie Boisbouvier, Simon Corbin, Axel Béasse, et al.Bulletin Du Cancer|January 3, 2006
[Targeted therapies and radiotherapy in colorectal cancer]David Azria, Nicolas MagnéBulletin Du Cancer|April 24, 2007
[New tools in adjuvant breast cancer radiotherapy]Yazid Belkacémi, David AzriaCritical Reviews in Oncology/Hematology|October 6, 2012
Radiation therapy and immunotherapy: implications for a combined cancer treatmentAntonin Levy, Cyrus Chargari, Morgane Cheminant, et al.International Journal of Cancer|March 19, 2019
An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancerLaura Bourillon, Céline Bourgier, Nadège Gaborit, et al.Bulletin Du Cancer|November 27, 2002
[Gemcitabine and pancreatic cancer]Patricia Prost, Marc Ychou, David AzriaInternational Journal of Radiation Oncology, Biology, Physics|January 22, 2020
Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer CellsLaura Bourillon, Sylvain Demontoy, Alexis Lenglet, et al.Radiation Oncology (London, England)|November 15, 2011
Mixed modality treatment planning of accelerated partial breast irradiation: to improve complex dosimetry casesMohamed El Nemr, Steve Heymann, Rodolfe Verstraet, et al.Bulletin Du Cancer|January 13, 2004
[External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients]Jean-Bernard Dubois, David Azria, Marc YchouCritical Reviews in Oncology/Hematology|February 16, 2015
Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapyJean-Philippe Spano, David Azria, Anthony GonçalvesPageof 30